Task: Answer the multiple-choice question.
Question: Which drug has a 30.587% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] Cc1cc(-c2ccccc2)c(C#N)c(=S)[nH]1
[b] CC(C)C(C)NC(=O)COc1ncnc2sccc12
[c] O=C(N/N=C/c1cccc(F)c1)c1c(O)c2ccccc2[nH]c1=O
Answer: b. CC(C)C(C)NC(=O)COc1ncnc2sccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)C(C)NC(=O)COc1ncnc2sccc12
CC(C)C(C)NC(=O)COc1ncnc2sccc12
N-(3-methylbutan-2-yl)-2-thieno[2,3-d]pyrimidin-4-yloxyacetamide